Sign In

Markus Goebel

Director at HAYA Therapeutics SA

Markus Goebel is a highly experienced Managing Director at Novartis Venture Fund, with a strong background in the Health Care Industry since 1990.

Throughout his career, Markus has excelled in product and company assessment, valuation, deal structures, and financials with a focus on Oncology, Nervous System, and gene therapy.

He holds an MBA with a dissertation on innovation in the Pharma industry and is a certified MD in Oncology/Haematology with over 10 years of experience in academia.

Markus has been involved in various roles such as Director at HAYA Therapeutics SA, CEO at M&G Advisors GmbH, Managing Director at Novartis Venture Fund, and leadership positions at Novartis and Roche.

His expertise spans across VC, BD&L, M&A, finance, deal structures, and valuation, with a proven track record of successfully concluding multiple deals.

He also brings Non-for-profit Board of Trustees experience to his professional profile.

Markus Goebel
Add to my network

Location

Zürich Area, Switzerland